Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, NewAmsterdam Pharma Company NV (NASDAQ: NAMS) closed at $20.20 up 0.40% from its previous closing price of $20.12. In other words, the price has increased by $0.40 from its previous closing price. On the day, 1.0 million shares were traded. NAMS stock price reached its highest trading level at $20.6667 during the session, while it also had its lowest trading level at $19.87.
Ratios:
For a deeper understanding of NewAmsterdam Pharma Company NV’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.61 and its Current Ratio is at 10.61. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On March 14, 2024, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $35.
On January 18, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $30.Guggenheim initiated its Buy rating on January 18, 2024, with a $30 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 18 ’24 when ForGrowth NAP B.V. sold 33,273 shares for $25.08 per share. The transaction valued at 834,440 led to the insider holds 11,778,760 shares of the business.
ForGrowth NAP B.V. sold 8,530 shares of NAMS for $213,436 on Nov 15 ’24. The 10% Owner now owns 11,812,033 shares after completing the transaction at $25.02 per share. On Nov 14 ’24, another insider, ForGrowth NAP B.V., who serves as the 10% Owner of the company, sold 9,832 shares for $25.01 each. As a result, the insider received 245,856 and left with 11,820,563 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NAMS now has a Market Capitalization of 1866195328 and an Enterprise Value of 1443971584. Its current Enterprise Value per Revenue stands at 42.983 whereas that against EBITDA is -7.845.
Stock Price History:
Over the past 52 weeks, NAMS has reached a high of $26.35, while it has fallen to a 52-week low of $8.90. The 50-Day Moving Average of the stock is 5.93%, while the 200-Day Moving Average is calculated to be 3.64%.
Shares Statistics:
For the past three months, NAMS has traded an average of 438.57K shares per day and 1030630 over the past ten days. A total of 82.47M shares are outstanding, with a floating share count of 42.91M. Insiders hold about 53.59% of the company’s shares, while institutions hold 40.61% stake in the company. Shares short for NAMS as of 1730332800 were 718042 with a Short Ratio of 1.64, compared to 1727654400 on 442964. Therefore, it implies a Short% of Shares Outstanding of 718042 and a Short% of Float of 1.2899999500000001.
